A&O NY lands $39bn trophy Novartis-Alcon mandate
Allen & Overy has bagged a lead advisory role opposite Cravath Swaine & Moore on the sale of eye-care company Alcon to Swiss pharmaceuticals company Novartis - a deal that could be worth as much as $39bn (£20bn). Cravath represented food giant Nestle on the sale of subsidiary Alcon, while A&O advised Novartis in a coup for the magic circle firm's US arm. New York senior partner and US law co-head Dan Cunningham led the team for A&O, along with New York public M&A chief Eric Shube.
This premium content is reserved for
Legal Week Subscribers.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now